AZ scores first 2022 PBS listing

Posted 20 December 2021 AM

AstraZeneca is first out of the gate for 2022, announcing Forxiga will be listed on the PBS from New Years Day providing Australians living with heart failure broader access to another treatment option that may help to reduce the number of hospitalisations and cardiovascular deaths.

Despite efforts to improve quality of life and survival, patients with heart failure continue to have a poor prognosis with cumulative mortality of approximately 31 per cent at one year and 50 per cent at five years.

To see the whole article, please login